Skip to main content

Marc Pellicer Sarasa

Institutions of which they are part

Biomedical Research in Cancer Stem Cells
Vall Hebron Institut de Recerca

Marc Pellicer Sarasa

Institutions of which they are part

Biomedical Research in Cancer Stem Cells
Vall Hebron Institut de Recerca

Projects

Desenvolupament de noves nanopartícules funcionals dirigides al nòdul limfàtic per a l'eliminació del reservori latent de VIH

IP: María José Buzón Gómez
Collaborators: Ibane Abasolo Olaortua, Félix Pumarola Segura, Juan Lorente Guerrero, Laura García Latorre, Jordi Temprana Salvador, Joaquin Seras Franzoso, Marc Pellicer Sarasa, David Perea Pérez, Simon Schwartz Navarro, Jordi Navarro Mercadé, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Judit Grau Exposito, Meritxell Genesca Ferrer, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael
Funding agency: Fundació La Marató de TV3
Funding: 199998.75
Reference: 20180510
Duration: 10/05/2019 - 31/12/2022

Oncologia i Patologia Molecular

IP: Matilde Lleonart Pajarin
Collaborators: Juan Lorente Guerrero, Margarita Alberola Ferranti, Marc Pellicer Sarasa
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1617
Duration: 01/01/2014 - 31/12/2016

Identificación de nuevas dianas terapéuticas basadas en micro-RNAs sobreexpresados en cáncer

IP: Matilde Lleonart Pajarin
Collaborators: Marc Pellicer Sarasa, Marta Garrido Pontnou, Carmela Iglesias i Felip
Funding agency: Instituto de Salud Carlos III
Funding: 147015
Reference: PI09/02193
Duration: 01/01/2010 - 30/04/2013

Terapia génica para el tratamiento del MNGIE (Mitochondrial Neurogastrointestinal Encephalomyopathy). Introducción del gen timidina fosforilasa en líneas celulares humanas y en un doble knock-out murino como modelos experimentales

IP: Ramon Martí Seves
Collaborators: Jordi Barquinero Mañez, Marc Pellicer Sarasa
Funding agency: Instituto de Salud Carlos III
Funding: 180895
Reference: PI060735
Duration: 01/01/2007 - 30/12/2009

Related news

The Biomedical Research in Cancer Stem Cells group at VHIR has identified a new therapeutic target and is working to find new therapies for this type of tumor.

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

Related professionals

Angel Michael Ortiz Zuñiga

Angel Michael Ortiz Zuñiga

Postdoctoral researcher
Diabetes and Metabolism
Read more
Manel Maymi Ballesteros

Manel Maymi Ballesteros

Predoctoral researcher
Cardiovascular Diseases
Read more
Laura Rodriguez Estévez

Laura Rodriguez Estévez

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Irene Salvador Roses

Irene Salvador Roses

Research technician
Donation and transplantation of organs, tissues and cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.